Cargando…

RARRES2’s impact on lipid metabolism in triple-negative breast cancer: a pathway to brain metastasis

Detalles Bibliográficos
Autor principal:	Shubhra, Quazi T. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496214/ https://www.ncbi.nlm.nih.gov/pubmed/37700352 http://dx.doi.org/10.1186/s40779-023-00480-w

Ejemplares similares

RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer
por: Li, Yi-Qun, et al.
Publicado: (2023)

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation
por: Morales, Mònica, et al.
Publicado: (2014)

RARRES3 regulates signal transduction through post-translational protein modifications
por: Hsu, Tzu-Hui, et al.
Publicado: (2015)

The metastasis suppressor RARRES3 as an endogenous inhibitor of the immunoproteasome expression in breast cancer cells
por: Anderson, Alison M., et al.
Publicado: (2017)

Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection
por: Shubhra, Quazi T.H., et al.
Publicado: (2023)

On the Therapeutic Potential of ERK4 in Triple-Negative Breast Cancer
por: Boudghene-Stambouli, Fadia, et al.
Publicado: (2022)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
por: Danai, Leyla, et al.
Publicado: (2023)

Sacituzumab govitecan in triple-negative breast cancer
por: de Nonneville, Alexandre, et al.
Publicado: (2022)

β→LACTAMASE-PRODUCING ANAEROBES
por: Reilly, Sheena, et al.
Publicado: (1980)

Immunotherapy for triple negative breast cancer: the end of the beginning or the beginning of the end?
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2022)

Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
por: Goel, Arun Kumar, et al.
Publicado: (2010)

Triple-Negative Breast Cancer: A Review of Current Curative Intent Therapies
por: MacDonald, Isaiah, et al.
Publicado: (2022)

Super-enhanced MARCO variant drives triple-negative breast cancer progression
por: Lin, Weei-Chin, et al.
Publicado: (2022)

Comment on “Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer”
por: Altundag, Kadri
Publicado: (2017)

Sacituzumab govitecan: ascending the treatment algorithm in triple negative breast cancer
por: Rozenblit, Mariya, et al.
Publicado: (2022)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
por: Li, Yaming, et al.
Publicado: (2019)

All-stage targeted therapy for the brain metastasis from triple-negative breast cancer
por: Luo, Zimiao, et al.
Publicado: (2023)

Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
por: Stefanski, Casey D., et al.
Publicado: (2022)

Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2019)

Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
por: Lee, Kha-Liang, et al.
Publicado: (2020)

Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN
por: Oldridge, E E, et al.
Publicado: (2013)

A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward
por: Rizzo, Alessandro, et al.
Publicado: (2022)

MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer
por: Mekky, Radwa Y., et al.
Publicado: (2023)

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancers
por: Rajarajan, Savitha, et al.
Publicado: (2023)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Rad51 supports triple negative breast cancer metastasis
por: Wiegmans, Adrian P, et al.
Publicado: (2014)

Wnt signaling in triple negative breast cancer is associated with metastasis
por: Dey, Nandini, et al.
Publicado: (2013)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
por: Lv, Yan, et al.
Publicado: (2021)

Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
por: Dong, Tieying, et al.
Publicado: (2017)

The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells
por: Mentoor, Ilze, et al.
Publicado: (2021)

Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
por: Maimouni, Sara, et al.
Publicado: (2018)

Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival
por: Maimouni, Sara, et al.
Publicado: (2021)

Comment to “Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis”
por: Altundag, Kadri
Publicado: (2016)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
por: Raman, Dayanidhi, et al.
Publicado: (2020)

Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition
por: Roy, Arpita, et al.
Publicado: (2017)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
por: Kuo, Wen-Hung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m8r0256jt5vt140vebg635nl57